THE PHARMACOLOGICAL SHOCK TREATMENT OF SCHIZOPHRENIA
Abstract
1. A two-year follow-up study of 1039 cases of dementia præcox treated by the pharmacological shock method in the New York state hospitals is presented and discussed.
2. It is recommended that statistical compilations include all the factors that seem to be related to the outcome of treatment.
3. Uniform recording of the treatment based upon the neurological signs of the insulin effect is advocated.
4. Uniform criteria for the interpretation of the results of treatment should be established.
5. The value of metrazol as a part of the pharmacological shock treatment is discussed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).